Free Trial

Healthcare Realty Trust (HR) Stock Forecast & Price Target

Healthcare Realty Trust logo
$17.49 +0.10 (+0.58%)
(As of 11/15/2024 ET)

Healthcare Realty Trust - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
4
Buy
1

Based on 6 Wall Street analysts who have issued ratings for Healthcare Realty Trust in the last 12 months, the stock has a consensus rating of "Hold." Out of the 6 analysts, 1 has given a sell rating, 4 have given a hold rating, and 1 has given a buy rating for HR.

Consensus Price Target

$17.17
-1.85% Downside
According to the 6 analysts' twelve-month price targets for Healthcare Realty Trust, the average price target is $17.17. The highest price target for HR is $18.00, while the lowest price target for HR is $15.00. The average price target represents a forecasted downside of -1.85% from the current price of $17.49.

HR Analyst Ratings Over Time

TypeCurrent Forecast
11/17/23 to 11/16/24
1 Month Ago
10/18/23 to 10/17/24
3 Months Ago
8/19/23 to 8/18/24
1 Year Ago
11/17/22 to 11/17/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$17.17$17.14$17.00$18.22
Forecasted Upside-1.85% Downside-4.71% Downside-1.62% Downside27.92% Upside
Consensus Rating
Hold
Hold
Hold
Hold
the biggest gold rally of our lifetimes? (Ad)

Commodities expert, Geof Smith, insists that the supercycle on gold is just getting warmed up. In fact, even though gold looks like this since he initially called a major bull run 11 months ago… He’s still predicting it will be the TOP trade of 2025. His free eBook explains why You see, the last time gold launched into a supercycle like this it surged 536% The time before that was over 1,000%... That’s why Geof released this urgent guide to help you. Most people think they’ve missed out, but he thinks we’re at the very beginning of what could be the largest gold rally of our lifetimes. But, believe it or not, Geof doesn’t think you should just buy and hold precious metals. He’ll share more about his approach inside the eBook and it might surprise you.

Tap here to read it

HR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Healthcare Realty Trust Stock vs. The Competition

TypeHealthcare Realty TrustFinance CompaniesS&P 500
Consensus Rating Score
2.00
2.49
2.50
Consensus RatingHoldHoldModerate Buy
Predicted Upside-1.85% Downside12.17% Upside9.92% Upside
News Sentiment Rating
Positive News

See Recent HR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/1/2024Wells Fargo & Company
3 of 5 stars
J. Feldman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderweight ➝ Underweight$16.00 ➝ $17.00-5.24%
8/7/2024Scotiabank
5 of 5 stars
 Boost TargetSector Perform ➝ Sector Perform$17.00 ➝ $18.00+0.95%
8/5/2024Wedbush
4 of 5 stars
R. Anderson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$15.00 ➝ $18.00+2.86%
3/6/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$19.00 ➝ $17.00+23.37%
2/20/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$19.00 ➝ $15.00+4.46%
1/30/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$18.00+8.86%
Central Bank Abandons USD (Ad)

Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold.

Click here now to get your free 'Protect Your Wealth' Guide.
10/24/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$17.00+18.55%
10/6/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform ➝ Market Perform$20.00 ➝ $17.00+13.18%
8/22/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$19.00 ➝ $17.00+2.38%
8/11/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$25.00 ➝ $24.00+32.89%
3/6/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral$23.00 ➝ $20.00+1.21%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:36 AM ET.


HR Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Healthcare Realty Trust is $17.17, with a high forecast of $18.00 and a low forecast of $15.00.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthcare Realty Trust in the last twelve months. There is currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" HR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HR, but not buy additional shares or sell existing shares.

According to analysts, Healthcare Realty Trust's stock has a predicted downside of -1.85% based on their 12-month stock forecasts.

Healthcare Realty Trust has been rated by research analysts at Wells Fargo & Company in the past 90 days.

Analysts like Healthcare Realty Trust less than other "finance" companies. The consensus rating score for Healthcare Realty Trust is 2.00 while the average consensus rating score for "finance" companies is 2.49. Learn more on how HR compares to other companies.


This page (NYSE:HR) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners